Comparison

Bedaquiline fumarate European Partner

Manufacturer TargetMol
Category
Type Molecules
Specific against other
Amount 100mg
Item no. TMO-T21023-100mg
CASRN 845533-86-0
eClass 6.1 32169090
eClass 9.0 32169090
Available
Short Description
Bedaquiline fumarate, a diarylquinoline antibiotic that targets ATP synthase, is effective for the treatment of Mycobacterium tuberculosis infections. It blocks the proton pump for ATP synthase of mycobacteria. It is the first member of a new class of drugs called diarylquinolines.
Shipping
cool pack
Storage
-20°
Target names or alias
R 403323 , R-403323 , R403323 , TMC 207 , TMC-207 , TMC207
Molecular Weight
671, 59
Pathway
Microbiology/Virology
Target
Antibacterial|||Antibiotic

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100mg
Available: In stock
available

Delivery expected until 4/18/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close